Resurfacing acne swipes

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Resurfacing acne swipes
Generic name
SALICYLIC ACID
Manufacturer
Oars And Alps LLC
Product type
HUMAN OTC DRUG
SPL set ID
efe14f46-c947-aea4-e053-2a95a90aad5f
SPL ID
44e861a1-92d4-6c98-e063-6394a90a7a94
Version
3
Effective date
2025-12-01
Source export date
2026-10-12
Source partition
1
Source file
https://download.open.fda.gov/drug/label/drug-label-0001-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-10-12/7928c8e8c6256620071a8b7e5b93eb8dfa543649c08d17a01ea02251012ba58c/drug-label-0001-of-0014.json.zip
Source manifest SHA-256
7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run
20261013T011858Z
Imported at
2026-10-13 01:25:12
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 2 matching rows.

warnings

Warnings For external use only Do not use if you have very sensitive skin or known allergy to aspirin Stop use ask a doctor If excessive itching, dryness, redness, burning or swelling occurs, or if these symptoms persist When using this product • Keep away from eyes, lips and other mucous membranes. If contact occurs, flush thoroughly with water. • Do not leave pad on the skin for an extended period of time. • Using other topical acne medications at the same time or immediately following use of this product may increase dryness or irritation of the skin. If this occurs, only one medication should be used unless directed by doctor

warnings and cautions

Other Information Sunburn Alert: This product contains an alpha hydroxy acid (AHA) that may increase your skin’s sensitivity to the sun and particularly the possibility of sunburn. Use a sunscreen, wear protective clothing, and limit sun exposure while using this product and for a week afterwards.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.